4.6 Article

Patient-reported outcome measures in core outcome sets targeted overlapping domains but through different instruments

期刊

JOURNAL OF CLINICAL EPIDEMIOLOGY
卷 136, 期 -, 页码 26-36

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2021.03.003

关键词

Core outcome set; COS; Patient-reported outcome measure; PRO; PROM; Outcomes research

资金

  1. Innovative Medicines Initiative 2 Joint Undertaking [116055]
  2. European Union
  3. European Federation of Pharmaceutical Industries and Associations (EFPIA)
  4. National Institute for Health Research (NIHR) [NF-SI_0513-10025]
  5. MRC Trials Methodology Research Partnership [MR/S014357/1]
  6. MRC [MR/S014357/1] Funding Source: UKRI

向作者/读者索取更多资源

This study reviewed core outcome sets (COS) with patient-reported outcomes measures (PROMs) and found that while most instruments cover broad health-related constructs, there are issues of resource overlap within and across different disease areas.
Objective: There is no comprehensive assessment of which patient-reported outcomes (PROs) are recommended in core outcome sets (COS), and how they should be measured. The aims of this study are to review COS that include patient-reported outcomes measures (PROMs), identify their target health domains, main characteristics, and their overlap within and across different disease areas. Study design and setting: We selected COS studies collected in a publicly available database that included at least one recommended PROM. We gathered information on study setting, disease area, and targeted outcome domains. Full-text of recommended instruments were obtained, and an analysis of their characteristics and content performed. We classified targeted domains according to a predefined 38-item taxonomy. Results: Overall, we identified 94 COS studies that recommended 323 unique instruments, of which: 87% were included in only one COS; 77% were disease-specific; 1.5% preference-based; and 61% corresponded to a full questionnaire. Most of the instruments covered broad health-related constructs, such as global quality of life (25%), physical functioning (22%), emotional functioning and wellbeing (7%). Conclusion: The wealth of recommended instruments observed even within disease areas does not fit with a vision of systematic, harmonized collection of PROM data in COS within and across disease areas. (c) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据